Subdermal Contraceptive Implants Market Share

  • Report ID: 5300
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Subdermal Contraceptive Implants Market Share

North American Market Forecast

Subdermal contraceptive implants market in North America is predicted to account for the largest share of 55% by 2037 impelled by the availability of contraceptive implants. Nexplanon which resembles a matchstick in size and is a tiny, thin rod is the implant that is offered in the US. Besides this, Canada has now authorized the use of Nexplanon to give patients in the country an essential and long-overdue expansion of their options for contraception. For instance, Women in the US had access to over 50% of the contraceptive products available globally, as compared to approximately 34% for Canadian women.

APAC Market Statistics

The APAC subdermal contraceptive implants market is estimated to be the second largest, during the forecast timeframe led by rising government’s initiatives to improve access to contraceptive methods. The Indian government has made important strides towards enhancing sexual and reproductive health at the national, local, and rural levels by launching various initiatives such as Mission Parivar Vikas, which will greatly expand access to family planning and contraceptives. For instance, lately, India's adoption of the Sustainable Development Goals (SDG) indicator over 3 intends to ensure that everyone has access to sexual and reproductive health care services by 2030 by meeting three-fourths of family planning needs with contemporary contraceptive methods.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5300
  • Published Date: Oct 09, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of subdermal contraceptive implants is assessed at USD 1.11 billion.

The subdermal contraceptive implants market size was over USD 1.08 billion in 2024 and is likely to reach USD 1.73 billion by the end of 2037, witnessing around 3.7% CAGR during the forecast period i.e., between 2025-2037. Rising count of unintended pregnancies and the rising governmental initiative to utilize contraceptive procedures will drive the market growth.

North America industry is estimated to hold largest revenue share 55% by 2037, impelled by availability of contraceptive implants in the region.

The major players in the market are Shanghai Dahua Pharmaceutical Co., Ltd, Bayer AG, Wyeth Pharmaceuticals, Baxter, Gerresheimer AG, Pfizer, Inc., Novartis AG, Schott AG, Eli Lilly and Company, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample